Hasil Pencarian - Ramesh Vishwakarma

Perbaiki Hasil
  1. 1
    Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort study

    Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort study oleh Khalid Al Sulaiman, Kholoud Al Aamer, Alaa Al Harthi, Saud Jaser, Abdulrahman Al Anazi, Sultan Al Subaie, Ramesh Vishwakarma

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Association between platelet count and multiorgan dysfunction and outcomes in patients with sepsis in the pediatric intensive care unit in Saudi Arabia

    Association between platelet count and multiorgan dysfunction and outcomes in patients with sepsis in the pediatric intensive care unit in Saudi Arabia oleh Tarek R. Hazwani, Wesam Bin Obaid, Fatimah Alowirdi, Rahaf Alsomali, Hamza Alali, Alaa Alsadoon, Moudi Alhamwah, Sara Alsubaiel, Bassam Alomar, Ramesh Vishwakarma, Yasser M. Kazzaz

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study

    The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study oleh Khalid Al Sulaiman, Abdulrahman Alshaya, Ohoud Aljuhani, Amjad Alsaeed, Nadiyah Alshehri, Ramesh Vishwakarma, Hamdan Alzahrani, Sara Althewaibi, Nawaf Alghamdi, Khalid Alhelal, Aisha Alharbi, Shmeylan Al Harbi

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study

    Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study oleh Khalid Al Sulaiman, Ohoud Aljuhani, Abdulrahman I. Al Shaya, Abdullah Kharbosh, Raed Kensara, Alhomaidi Al Guwairy, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Ramesh Vishwakarma, Ghazwa B. Korayem

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective study

    The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective study oleh Khalid Al Sulaiman, Nouf Al Qahtani, Mashael Al Muqrin, Maram Al Dossari, Ali Al Wabel, Tareq Al Sulaiman, Ramesh Vishwakarma, Abdulaziz Alolayan, Fatimah Abudayah, Ghazwa B. Korayem, Ohoud Aljuhani

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study

    Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study oleh Khalid Al Sulaiman, Ohoud Aljuhani, Khalid Bin Saleh, Hisham A. Badreldin, Abdullah Al Harthi, Mohammed Alenazi, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Abdullah M. Alhammad, Ramesh Vishwakarma, Sarah Aldekhyl

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study

    Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study oleh Ohoud Aljuhani, Khalid Al Sulaiman, Awatif Hafiz, Khalid Eljaaly, Aisha Alharbi, Rahmah Algarni, Sarah Al Homaid, Khawla Kahtani, Tareq Alsulaiman, Ramesh Vishwakarma, Ghassan Al Ghamdi, Mai Alalawi, Ghazwa B. Korayem

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Author Correction: Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study

    Author Correction: Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study oleh Khalid Al Sulaiman, Ohoud Aljuhani, Khalid Bin Saleh, Hisham A. Badreldin, Abdullah Al Harthi, Mohammed Alenazi, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Abdullah M. Alhammad, Ramesh Vishwakarma, Sarah Aldekhyl

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): A multicenter cohort study

    Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): A multicenter cohort study oleh Khalid Bin Saleh, Awattif Hafiz, Khalid Alsulaiman, Ohoud Aljuhani, Shmeylan Alharbi, Aisha Alharbi, Ramesh Vishwakarma, Abdulkareem Albekairy, Abdulmalik Alkathiri, Faisal Alanazi, Ghada Almujarri, Seba Alobathani, Yazeed Alharbi, Hosam M. Zowawi, Hisham A. Badreldin

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study

    Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study oleh Khalid Al Sulaiman, Hisham A. Badreldin, Ghazwa B. Korayem, Abeer A. Alenazi, Faisal Alsuwayyid, Abdulrahman Alrashidi, Mohammed Alhijris, Faisal Almutairi, Fahad Alharthi, Ramesh Vishwakarma, Omar Al Shaya, Abdulrahman Al Amri, Saqiba Tayyab, Abdulkareem M. Al Bekairy, Ohoud Aljuhani

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study

    Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study oleh Ohoud Aljuhani, Khalid Al Sulaiman, Adel Alshabasy, Khalid Eljaaly, Abdulrahman I. Al Shaya, Haytham Noureldeen, Mohammed Aboudeif, Bodoor Al Dosari, Amina Alkhalaf, Ghazwa B. Korayem, Muneera M. Aleissa, Hisham A. Badreldin, Shmeylan Al Harbi, Abdullah Alhammad, Ramesh Vishwakarma

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study

    Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study oleh Khalid Al Sulaiman, Ohoud Aljuhani, Maram Al Dossari, Asma Alshahrani, Aisha Alharbi, Rahmah Algarni, Majed Al Jeraisy, Shmeylan Al Harbi, Abdulmalik Al Katheri, Fahad Al Eidan, Abdulkareem M. Al Bekairy, Nouf Al Qahtani, Mashael Al Muqrin, Ramesh Vishwakarma, Ghassan Al Ghamdi

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study

    Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study oleh Khalid Al Sulaiman, Mashael Al Mutairi, Omar Al Harbi, Alanoud Al Duraihim, Sara Aldosary, Haifa Al Khalil, Abdulrahman Al Shaya, Shmeylan Al Harbi, Nouf Alotaibi, Kholoud Al Aamer, Ramesh Vishwakarma, Mohammed Al Asiri, Ohoud Aljuhani, Abdulmalik Al Katheri, Abdulkareem M. Al Bekairy

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study

    The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study oleh Ohoud Aljuhani, Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, Samiah Alsohimi, Rahaf Alqahtani, Saeedah Alfaifi, Aisha Alharbi, Azzah AlKhayrat, Ahmed Hattan, Meshal Albassam, Omar A. Almohammed, Atheer Alkeraidees, Dhay A. Alonazi, Weam F. Alsalman, Ghaliah Aldamegh, Rasha Alshahrani, Ramesh Vishwakarma

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study

    The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study oleh Khalid Al Sulaiman, Ohoud Aljuhani, Abdullah M. Alhammad, Kholoud Al Aamer, Sara Alshehri, Abdulmohsen Alhuwahmel, Abdullah Kharbosh, Areej Alshehri, Hanan Alshareef, Ibrahim Al Sulaihim, Albandari Alghamdi, Shmeylan Al Harbi, Ramesh Vishwakarma, Numan Alabdan, Yousef Alrajhi, Abdulmalik Al Katheri, Abeer A. Alenazi, Mai Alalawi, Ghassan Al Ghamdi

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study

    The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study oleh Ghazwa B. Korayem, Ohoud Aljuhani, Ali F. Altebainawi, Abdulrahman I. Al Shaya, Lina I. Alnajjar, Abdulrahman Alissa, Mohammed Aldhaeefi, Raed Kensara, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Omar Alhuthaili, Ramesh Vishwakarma, Namareq Aldardeer, Khalid Eljaaly, Aisha Alharbi, Shmeylan Al Harbi, Abdulmalik Al Katheri, Abdulkareem M. Al Bekairy, Ahmed Aljedai, Khalid Al Sulaiman

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study

    When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study oleh Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Mashael AlFaifi, Majed Nahari, Alaa Almagthali, Abrar K. Thabit, Raghad Alhajaji, Reham Alharbi, Khawla Kahtani, Abeer A. Alenazi, Aisha Alharbi, Munirah M. Alghwainm, Sara M. Alotaibi, Yazeed S. Alghamdi, Samar Alotaibi, Shaden H. Alonazi, Jumanah M. Almutairi, Ramesh Vishwakarma

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study

    Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study oleh Ohoud Aljuhani, Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, Abdulrahman Alshaya, Majed Nahari, Khuzama Alsamnan, Munirah A. Alkathiri, Bodoor S. Al-Dosari, Abeer A. Alenazi, Samiah Alsohimi, Lina I. Alnajjar, Mashael Alfaifi, Nora AlQussair, Reem M. Alanazi, Munirah F. Alhmoud, Nadin L. Alanazi, Hadeel Alkofide, Aljawharah M. Alenezi, Ramesh Vishwakarma

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study

    Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study oleh Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Daniah AlMohammady, Amjaad Alfahed, Elaf F. Altebainawi, Mohammed Aldhaeefi, Hisham A. Badreldin, Ramesh Vishwakarma, Faisal E. Almutairi, Abeer A. Alenazi, Thamer Alsulaiman, Rahaf Ali Alqahtani, Fahad Al Dhahri, Namareq Aldardeer, Ahmed O. Alenazi, Shmeylan Al Harbi, Raed Kensara, Mai Alalawi, Khalid Al Sulaiman

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study

    The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study oleh Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Meshal S. Alotaibi, Noura A. Alrakban, Ragia H. Ghoneim, Ramesh Vishwakarma, Abdulrahman I. Al Shaya, Shmeylan Al Harbi, Jawaher Gramish, Dahlia M. Almutairi, Ghada Alqannam, Faisal F. Alamri, Abdullah F. Alharthi, Mashael Alfaifi, Abdullah Al Amer, Abeer A. Alenazi, Norah Bin Aydan, Mai Alalawi, Khalid Al Sulaiman

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: